Terem Technologies has conducted what it claims is the first study into the growth of female technology entrepreneurs, with surprising results. [ + ]

Thanks to a computer program developed at Edith Cowan University, plant classification could become as simple as taking a photo. [ + ]

Specialised Therapeutics Australia has formed an exclusive licence and commercialisation agreement with PharmaMar to market and distribute the oncology drug APLIDIN (plitidepsin) in Australia and New Zealand. [ + ]

Clarity Pharmaceuticals and the University of Melbourne have been awarded an ARC Linkage grant to fund the development of new agents for diagnostic imaging using PET. The ultimate aim of the project is to try to improve molecular imaging of the brain for various disorders. [ + ]

Three Australian research teams will contribute to a global effort to combat the growing incidence of type 2 diabetes, having received NHMRC funding as part of a multicountry grant call through the Global Alliance for Chronic Diseases. [ + ]

Professor Allan Pacey has released an inside look at the process of conception in the human body, framing it as an amazing race between 250 million competitors. [ + ]

Drug developer Paradigm Biopharmaceuticals has listed on the Australian Securities Exchange for the first time. [ + ]

The Westmead Millennium Institute for Medical Research will next month host the 11th annual Indo-Australian Biotechnology Conference, providing an opportunity for Australian medical researchers to forge closer links with their Indian counterparts. [ + ]

The increasing amount of money spent on biomedical research in the US over the past 50 years has resulted in diminished return on investment in terms of life-expectancy gains and new drug approvals, according to researchers from the Johns Hopkins Bloomberg School of Public Health. [ + ]

Prima BioMed will receive a clinical milestone payment from Novartis relating to the latter's IMP701 LAG-3 antibody, which is being trialled for the treatment of cancer. [ + ]

Australian and German scientists have collaborated on the demonstration of a diamond laser that is said to be 20 times more powerful than previous diamond lasers. [ + ]

Five finalists in the 2015 Research Commercialisation Awards, presented by Knowledge Commercialisation Australasia, have been announced. [ + ]

A newly developed reference material, containing a mixture of freeze-dried, powdered shellfish, will help laboratories accurately measure radioactive contamination in seawater. [ + ]

Oxford University spin-out company Oxitec, which is commercialising technology to control disease-carrying insects and pests, has been sold to synthetic biology specialist Intrexon Corporation for US$160 million. [ + ]

US-based company ANI Pharmaceuticals has agreed to market and distribute up to 18 generic pharmaceutical products which have recently been acquired by IDT Australia. [ + ]